Mark Aaron Fiala
Researcher · Medicine
Source-listed associations: Washington University in St. Louis; Alvin J. Siteman Cancer Center
United States
Mark Aaron Fiala has indexed research in Medicine. Research topics in the source record include Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology.
Read biography ↓Biography, research & contributions
Mark Aaron Fiala has indexed research in Medicine. Research topics in the source record include Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology.
Research and publications
The selected publications below appear in both the public ORCID record and the OpenAlex author record. The list is a subset of the researcher’s work.
Institutional record
OpenAlex lists Washington University in St. Louis; Alvin J. Siteman Cancer Center among its last-known institutional associations. These records do not confirm a current appointment.
Identity and source coverage
The public ORCID name and at least one education or employment institution were matched with the OpenAlex record on 2026-10-03. Publication identifiers were also compared between the two sources. Positions, education, honors and portrait are included only when separately documented.
At a glance
- Full name
- Mark Aaron Fiala
- Alternative names
- Fiala, M.A. Fiala, Mark M A Fiala M Fiala M. Fiala M.A. Fiala Mark A Fiala Mark A. Fiala Mark Aaron Fiala Mark Fiala
- Fields
- Medicine
- ORCID
- 0000-0002-0208-5023
- OpenAlex ID
- A5021003906
Research interests
- Multiple Myeloma Research and Treatments
- Protein Degradation and Inhibitors
- Cancer Treatment and Pharmacology
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
- Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 ↗2021 · JAMA OncologyDOI: 10.1001/jamaoncol.2021.1799
- Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome ↗2015 · Transplantation and Cellular TherapyDOI: 10.1016/j.bbmt.2015.05.026
- Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer ↗2022 · JAMA Network OpenDOI: 10.1001/jamanetworkopen.2022.4304
- Socioeconomic status is independently associated with overall survival in patients with multiple myeloma ↗2015 · Leukemia & lymphoma/Leukemia and lymphomaDOI: 10.3109/10428194.2015.1011156
- Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma Patients ↗2013 · Clinical Lymphoma Myeloma & LeukemiaDOI: 10.1016/j.clml.2013.09.013
Citation & publication trends
Annual source counts; separate scales. OpenAlex coverage may be incomplete for historical researchers.
View exact annual counts
| Year | Publications | Citations |
|---|---|---|
| 1985 | 1 | 0 |
| 1996 | 1 | 66 |
| 2002 | 5 | 40 |
| 2003 | 2 | 24 |
| 2004 | 5 | 107 |
| 2005 | 12 | 1134 |
| 2006 | 7 | 50 |
| 2007 | 6 | 115 |
| 2008 | 6 | 109 |
| 2009 | 4 | 247 |
| 2010 | 3 | 8 |
| 2011 | 9 | 45 |
| 2012 | 8 | 13 |
| 2013 | 9 | 142 |
| 2014 | 13 | 101 |
| 2015 | 20 | 438 |
| 2016 | 17 | 223 |
| 2017 | 31 | 451 |
| 2018 | 27 | 551 |
| 2019 | 43 | 1124 |
| 2020 | 24 | 420 |
| 2021 | 20 | 541 |
| 2022 | 29 | 318 |
| 2023 | 77 | 280 |
| 2024 | 36 | 112 |
| 2025 | 35 | 68 |
| 2026 | 13 | 14 |
Source: OpenAlex · Retrieved 2026-10-03T06:38:08+00:00. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- 188OpenAlex citations
- Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome ↗2015-06-06 · Transplantation and Cellular Therapy164OpenAlex citations
- Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer ↗2022-03-28 · JAMA Network Open73OpenAlex citations
- Socioeconomic status is independently associated with overall survival in patients with multiple myeloma ↗2015-02-04 · Leukemia & lymphoma/Leukemia and lymphoma73OpenAlex citations
- Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma Patients ↗2013-10-03 · Clinical Lymphoma Myeloma & Leukemia67OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study ↗2023-05-10 · Blood Cancer Journal
- Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 ↗2022-11-03 · JAMA Oncology
- Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer ↗2022-03-28 · JAMA Network Open
- Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome ↗2015-06-06 · Transplantation and Cellular Therapy
Journals published in
- Blood Cancer Journal
- Clinical Lymphoma Myeloma & Leukemia
- Diabetes
- JAMA Network Open
- JAMA Oncology
- Transplantation and Cellular Therapy
Related publishers
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: Pending review · Last data update: 2026-10-03T08:10:01+00:00
Automated identity and publication-source comparison: 2026-10-03T07:03:33+00:00. This is separate from manual editorial review and profile ownership.
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.